Winton Group LTD Glycomimetics Inc Transaction History

Winton Group LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$9.96 - $13.44 $110,805 - $149,520	-11,125 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$8.47 - $14.71 $15,373 - $26,698	-1,815 Reduced 14.03%	11,125 $105,000
Q3 2018 Nov 02, 2018	BUY	$13.7 - $17.12 $177,278 - $221,532	12,940 New	12,940 $0

17.6M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $14.2M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.